GLOW is a pre-mixed injectable peptide blend containing three regenerative compounds in a single vial: GHK-Cu (copper peptide) at 50 mg, TB-500 (Thymosin Beta-4 fragment) at 10 mg, and BPC-157 (Body Protection Compound) at 10 mg, totaling 70 mg per vial
- Validation: Validate the mixing process to ensure consistent production of uniform batches, including testing for content uniformity and particle size distribution
However, combining the two should be decided by a qualified provider familiar with both formulations
Unless you use it in the right way and at the right time, it wont give you the desired results, no matter how many different brands you experiment with
Tirzepatide Overview Tirzepatide is a dual agonist that targets both the GLP-1 and GIP receptors
Cell Discov 10, 77 (2024)